How much funding has Cerevance raised?

Cerevance has raised $184.5M in total funding, most recently a Venture Round.

Who are Cerevance's investors?

Cerevance's investors include GV (Google Ventures), Bill Gates, Foresite Capital, Takeda (JP), Lightstone Ventures.

Where is Cerevance headquartered?

Cerevance is headquartered in Cambridge, United Kingdom.

How many employees does Cerevance have?

Cerevance has 51-200 employees.

Cerevance

Cambridge, United Kingdom · Founded 2016 · $184.5M raised

Biotech

Headquarters: Cambridge
Employees: 51–200
Founded: 2016
Business Model: B2B

Website: cerevance.com
Total Funding: $184.5M
Last Round: $47.0M Venture RoundApr 2024
Rounds: 5

About

Cerevance develops cell-type specific treatments for CNS disorders including Parkinson's, Alzheimer's, and ALS. Using over 26,000 human brain tissue samples and its proprietary NETSseq platform, the company identifies novel drug targets with advanced machine learning to move beyond traditional dopamine-based therapies.

Summary

Cerevance is a Biotech company based in Cambridge, United Kingdom, founded in 2016. It has raised $184.5M in total across 5 rounds, most recently a $47.0M Venture Round round in Apr 2024. Investors include GV (Google Ventures), Bill Gates and Foresite Capital.